osein-hydroxyapatite compound

Ukraine

Drugs containing this active substance

  • OSTEOGENON

    The drug is used for the prevention and treatment of osteoporosis, as well as for the prevention or treatment of calcium deficiency. It may also be prescribed as adjuvant therapy to improve bone growth in cases of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    osein-hydroxyapatite compound 830 mg

    ATC: M05BX

    Manufacturer: Pierre Fabre Medicaments Production